Identifying genetic causes of developmental diseases
Official title: Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).
Run by Centre Hospitalier Universitaire Dijon · NCT03287193 · Data updated 2026-11-12
This study is trying to find the genetic causes of over 3000 developmental disorders by looking at blood samples from patients to help families understand these conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 850 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Status | Recruiting |
| Started | March 13, 2017 |
| Main results expected | March 2027 |
| Study ends | December 2027 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT03287193 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include fetuses, children, and adults with unexplained developmental anomalies.
✕Probably not a fit
Patients without national health insurance coverage may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify the molecular and pathophysiological bases of developmental anomalies, which encompass over 3000 different conditions. By utilizing next-generation sequencing and analyzing blood samples from patients, the study seeks to uncover genetic factors that contribute to these disorders. Despite advancements in genetic research, many individuals with severe developmental anomalies remain undiagnosed, highlighting the need for this investigation. The findings could enhance genetic counseling for affected families and improve understanding of these complex conditions.
Why it matters
Potential benefit: If successful, this study could lead to better genetic diagnoses and counseling for patients with developmental anomalies.
How similar studies have gone: Other studies utilizing next-generation sequencing have shown promise in identifying genetic causes of rare diseases, suggesting a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Patients (children or adults) with a suspected rare disease (or rare form of a common disease) of genetic origin for which the molecular basis is not known, or for which the understanding of the physiopathological mechanism is imperfectly known. OR -Foetuses with developmental abnormalities for which the molecular basis is not known, or for which the understanding of the physiopathological mechanism is imperfectly known. OR * Apparently healthy relatives or controls AND * Consent of the patient or his/her legal representative * Suitable level of understanding Exclusion Criteria: * Patients without national health insurance cover
Where it's running
-
Chu Dijon Bourogne
Dijon, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chorioretinal Imaging and Vascular Biomarkers in Ultra-Trail Runners
This study tests whether noninvasive eye imaging can reveal retinal and choroidal blood vessel changes in ultra-trail runners compared with active controls.
-
Lipid and mitochondrial clues in aortic aneurysm with bicuspid or tricuspid valves
This study tests whether inflammatory and metabolic signatures in myeloid cells and aortic tissue differ between patients with bicuspid versus tricuspid aortic valves who need surgery for ascending aortic aneurysm.
-
Value of trio genome sequencing in early-onset and atypical psychiatric disorders
This study tests whether sequencing the genomes of a patient and both biological parents can help explain early-onset or unusual psychiatric disorders in people without intellectual disability or congenital anomalies.
-
Pupillometry to predict postoperative pain after heart surgery
We’re testing whether measuring pupil responses can help predict how much pain a patient will feel after heart surgery once tubes come out and the patient can communicate.
-
BDNF Levels and Atrial Cardiomyopathy in People Having AF Ablation
This study tests whether circulating BDNF levels are linked to atrial cardiomyopathy in adults having their first ablation for persistent atrial fibrillation.
-
Cardiac Amyloidosis: See if Intracardiac Thrombi are Common on CT
This study tests whether a contrast-enhanced cardiac CT can reliably detect intracardiac thrombi in adults with cardiac amyloidosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.